Vistagen, a biopharmaceutical company focused on neuroscience, has appointed Dr. Angel S. Angelov as its new Chief Medical Officer effective May 18, 2026. Dr. Angelov brings over two decades of experience in clinical development and medical affairs, having worked with notable companies like Karuna and Novartis. His expertise will aid Vistagen in advancing its innovative intranasal product candidates, known as pherines, which aim to treat conditions such as social anxiety disorder and major depressive disorder. Vistagen is committed to reshaping patient care through these novel therapies.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.biospace.com/press-releases/vistagen-appoints-angel-s-angelov-md-mba-as-chief-medical-officer
